Chromosomal Microarray Testing
In Patients with Development Delay, Autism or other Congenital Anomalies
Click CC to turn on closed captioning.
Chromosomal microarray testing is recommended as the first-tier test to detect chromosomal imbalances in persons with developmental delay/intellectual disability, autism spectrum disorders, or multiple congenital anomalies. Interpretation of test results is a complex process and detailed clinical information and genetic consultation are helpful for accurate interpretation.
- Erik Thorland, PhD, Director of the Mayo Clinic Cytogenetics Laboratory at Mayo Clinic in Rochester, Minnesota
- Karen Wain, MS, Genetic Counselor in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Rochester, Minnesota
Feedback and Questions
- Complete the 4-question survey that appears after the presentation.
- During the survey, you can submit questions to the presenter. All questions and answers will be published on the Beyond Hot Topic page approximately one month after the Hot Topic posting.
- Array Comparative Genomic Hybridization (aCGH), Whole Genome, Constitutional
- Array Comparative Genomic Hybridization (aCGH) Parental Testing, FISH
Forward to a Colleague
Share this presentation with:
- Medical Geneticists
- Genetic Counselors
If you have questions, e-mail .